Ronald R Blanck - Net Worth and Insider Trading
Ronald R Blanck Net Worth
The estimated net worth of Ronald R Blanck is at least $20 dollars as of 2024-11-13. Ronald R Blanck is the Director of Tenax Therapeutics Inc and owns about 4 shares of Tenax Therapeutics Inc (TENX) stock worth over $20. Details can be seen in Ronald R Blanck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald R Blanck has not made any transactions after 2020-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ronald R Blanck
Ronald R Blanck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald R Blanck owns 1 companies in total, including Tenax Therapeutics Inc (TENX) .
Click here to see the complete history of Ronald R Blanck’s form 4 insider trades.
Insider Ownership Summary of Ronald R Blanck
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TENX | Tenax Therapeutics Inc | 2020-05-18 | director |
Ronald R Blanck Latest Holdings Summary
Ronald R Blanck currently owns a total of 1 stock. Ronald R Blanck owns 4 shares of Tenax Therapeutics Inc (TENX) as of May 18, 2020, with a value of $20.
Latest Holdings of Ronald R Blanck
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TENX | Tenax Therapeutics Inc | 2020-05-18 | 4 | 4.94 | 20 |
Holding Weightings of Ronald R Blanck
Ronald R Blanck Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald R Blanck has made a total of 1 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 3 shares on May 18, 2020, which cost Ronald R Blanck around $4,750.
Insider Trading History of Ronald R Blanck
- 1
Ronald R Blanck Trading Performance
GuruFocus tracks the stock performance after each of Ronald R Blanck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald R Blanck is -9.05%. GuruFocus also compares Ronald R Blanck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald R Blanck within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ronald R Blanck's insider trading performs compared to the benchmark.
Performance of Ronald R Blanck
Ronald R Blanck Ownership Network
Ownership Network List of Ronald R Blanck
Ownership Network Relation of Ronald R Blanck
Ronald R Blanck Owned Company Details
What does Tenax Therapeutics Inc do?
Who are the key executives at Tenax Therapeutics Inc?
Ronald R Blanck is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .
Tenax Therapeutics Inc (TENX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tenax Therapeutics Inc Insider Transactions
Ronald R Blanck Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald R Blanck. You might contact Ronald R Blanck via mailing address: 2001 Walnut Hill Lane, Irving Tx 75038.